試す - 無料

PackPlus redefines business opportunities in packaging

Chronicle Pharmabiz

|

July 24, 2025

THE packaging technology sector is undergoing significant transformation, driven by changing consumer demands, sustainability pressures, and rapid technological advancements. The packaging industry in India is poised for major growth and transformation like never before, driven by a combination of innovative practices and emerging trends.

The bright growth prospects are underpinned by the country’s robust pharmaceutical industry, competitive manufacturing capabilities, and increasing demand for advanced technology.

Some of the latest trends in pharma packaging include accessibility for patients, eco-friendly and sustainable packaging, ease of production, child-resistant packaging, user-friendly packaging, tamper-evident packaging.

Pharmaceutical packaging trends are increasingly focused on patient safety, sustainable practices, and digital enhancements. Additionally, there is a growing emphasis on anti-counterfeiting measures, traceability, and personalized packaging to address specific patient needs.

Integrating technology like RFID tags, NFC chips or QR codes provide information about the product, including authenticity, expiration dates, and usage instructions. Focus on eco-friendly materials, recyclable packaging, and innovative designs helps to minimize waste and environmental impact.

Technologies like holograms, colour-shifting inks, and other security features help to fight counterfeit products. Now there are more systems to track medication throughout the supply chain and ensure authenticity.

Integrating digital elements into packaging provide patient information, compliance reminders, and real-time monitoring. Increasing automation in pharmaceutical packaging helps to improve efficiency and reduce human error.

With the rise in medication complexity and the need to ensure absolute product integrity, packaging design is evolving to address these issues with inventions such as pre-filled syringes, auto-injectors.

The PackPlus event

While the packaging sector is thus witnessing major changes, PackPlus, India’s biggest event for packaging, converting and supply chain, being held from July 31 to August 2, 2025 at Pragati Maidan, New Delhi, will be showcasing solutions that shape the future of packaging.

Chronicle Pharmabiz からのその他のストーリー

Chronicle Pharmabiz

US FDA fortifies alliance with Telangana DCA

A high-level delegation from the US FDA concluded a significant meeting with the DCA in Telangana, two days ago, at the DCA office in Hyderabad.

time to read

2 mins

December 11, 2025

Chronicle Pharmabiz

India exploring possibilities to expand WHO standards for Indian medicines

INDIA is looking at possibilities to expand the World Health Organisation (WHO) global benchmarking standards for medicines, in order to unify and strengthen the drug regulatory mechanism for safety, quality and efficacy of medicines sold in the country.

time to read

1 min

December 11, 2025

Chronicle Pharmabiz

Eli Lilly gets US FDA approval for Jaypirca

Eli Lilly and Company announced that the US Food and Drug Administration (FDA) has granted approval to Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets) for the treatment of adults with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma (CLL/SLL) who have previously been treated with a covalent Bruton tyrosine kinase (BTK) inhibitor.

time to read

1 mins

December 11, 2025

Chronicle Pharmabiz

Haryana DCA focuses on quality overhaul

THE Haryana drug control administration (DCA) is undertaking a major organizational overhaul focused on quality system upgrades and regulatory capacity building, particularly in response to the revised Schedule M norms.

time to read

2 mins

December 11, 2025

Chronicle Pharmabiz

DoC seeks inputs on trade issues faced with Japan

THE Department of Commerce (DoC), under the Union Commerce Ministry, has sought inputs from the industry on specific issues being faced in pharma trade with Japan.

time to read

1 min

December 11, 2025

Chronicle Pharmabiz

AIOCD asks traders to strictly comply with ban on 35 FDCs

THE All India Organisation of Chemists and Druggists (AIOCD) has issued an urgent internal circular to all its state and Union territory trade bodies, demanding immediate and strict compliance with the ban on 35 fixed dose combinations (FDCs).

time to read

3 mins

December 11, 2025

Chronicle Pharmabiz

US FDA approves Bristol Myers Squibb's Breyanzi

Bristol Myers Squibb announced that the US Food and Drug Administration (FDA) has granted approval of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) who have received at least two prior lines of systemic therapy.

time to read

2 mins

December 11, 2025

Chronicle Pharmabiz

CN Water presents AQU@Sense MB

CN Water is now combining core water-system expertise with digital assurance has launched AQU@Sense which delivers microbial test results in under 30 minutes, replacing traditional 5 to 7 days culture based methods.

time to read

1 min

December 11, 2025

Chronicle Pharmabiz

Pharma logistics sees policy push as key catalyst for growth

INDIAN pharma's logistics sector is getting major boost from emerging policy support.

time to read

2 mins

December 11, 2025

Chronicle Pharmabiz

Lack of financial aid, expertise mar MSME prospects to meet revised Sch M deadline

INDUSTRY experts have raised alarm that lack of financial assistance and guidance on technical expertise have marred pharma MSMEs’ prospects to comply with revised Schedule M guidelines of December 31, 2025.

time to read

2 mins

December 11, 2025

Listen

Translate

Share

-
+

Change font size